Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Business Insurance
Article
Business Insurance Video: Comp Spotlight with Mike Cwynar
Workers' Comp
Article
The Shifting Landscape of Medical Costs: How Workers’ Compensation is Becoming a Payor of Last Resort
As open enrollment season is in full swing and the future of the Affordable Care Act's (ACA) enhanced premium tax credits remain uncertain, employe
Business Insurance
In the News
COVID comp claims keep landing in courts, with trend seen continuing
Workers' Comp
Article
Person-First Support Drives Better Recovery and Return-to-Work Results
Mental health isn’t a side note in workers’ comp anymore.
Workers' Comp
Article
Ask The Pharmacist: What Adjusters Need to Know About Trubrexa, a High-Cost Topical Analgesic
Are private-label topicals like Trubrexa worth the cost in workers’ comp? Private label topical analgesics (PLTAs) continue to push p
Mitchell
News Release
Mitchell Expands Canadian Alternate Parts Network with the Addition of New Suppliers
Live pricing and inventory data from seven of the country’s leading recycled parts providers is now available from within Mitchell Cloud Estim